Letter to the Editor
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. May 15, 2022; 13(5): 420-421
Published online May 15, 2022. doi: 10.4239/wjd.v13.i5.420
Admission hemoglobin level and prognosis of type 2 diabetes mellitus and possible confounding factors: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Pathum Sookaromdee, Private Consultant, Private Academic Consultant, Bangkok 23020202, Thailand
Viroj Wiwanitkit, Department of Community Medicine, DY Patil University, Pune 2223043003, India
Author contributions: Sookaromdee P gave ideas, analyzed the data, wrote the manuscript, revising and approving final submission; Wiwanitkit V gave ideas, analyzed the data, revising, supervising and approving final submission; All authors have read and approve the final manuscript.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Pathum Sookaromdee, PhD, Adjunct Professor, Private Consultant, Private Academic Consultant, 11 Bangkok 112, Bangkok 23020202, Thailand. pathumsook@gmail.com
Received: January 19, 2022
Peer-review started: January 19, 2022
First decision: March 11, 2022
Revised: March 12, 2022
Accepted: April 20, 2022
Article in press: April 20, 2022
Published online: May 15, 2022
Core Tip

Core Tip: This letter to editor discussing on the publication on admission hemoglobin level and prognosis of type 2 diabetes mellitus. Concerns on clinal application are raised and discussed.